Journal article icon

Journal article

Can prebiotics assist in the management of cognition and weight gain in schizophrenia?

Abstract:

Schizophrenia is among the top half of the 25 leading causes of disabilities worldwide with a 10–20 year decrease in life expectancy. Ineffective pharmacotherapy in the management of cognitive deficits and weight gain are known to be significant contributors; therefore interventions that may mitigate one, or both, of these parameters would be highly beneficial. Manipulation of the gut microbiome using dietary supplements such as prebiotics may be one such intervention. Preclinical studies hav...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted Manuscript

Actions


Access Document


Files:
Publisher copy:
10.1016/j.psyneuen.2018.05.027

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Psychiatry
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Psychiatry
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Psychiatry
Oxford college:
All Souls College
Role:
Author
ORCID:
0000-0002-4972-8786
Publisher:
Elsevier Publisher's website
Journal:
Psychoneuroendocrinology Journal website
Volume:
95
Pages:
179–185
Publication date:
2018-05-19
Acceptance date:
2018-05-18
DOI:
EISSN:
1873-3360
ISSN:
0306-4530
Pubs id:
pubs:848146
URN:
uri:ae03bef0-958a-4a9e-a945-c883c9613d34
UUID:
uuid:ae03bef0-958a-4a9e-a945-c883c9613d34
Local pid:
pubs:848146

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP